ARIAD Pharmaceuticals Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ARIAD Pharmaceuticals

ARIA 23.99

0.0%

Feb 17 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Mike McFarland who wrote (351)	10/6/1998 7:00:00 PM
From: Mike McFarland	Read Replies (1) of 4474

So, how many of these so-called "Nuclear Factors" are there? I am guessing by the lettering scheme there are a couple dozen at most? More references which sound interesting: NF-kappa B: a pivotal role in asthma and a new target for therapy. Trends Pharmacol Sci. 1997 Feb;18(2):46-50. Review. No abstract available. PMID: 9090308; UI: 97245640. [Glucocorticosteroids and ambroxol inhibit secretion of inflammatory cytokines in tracheobronchial epithelial cells: Possible role of the NF-kappa B transcription factor]. Pneumologie. 1997 May;51(5):491-2. German. No abstract available. PMID: 9265149; UI: 97342273. The allergen Der p1 induces NF-kappaB activation through interference with IkappaB alpha function in asthmatic bronchial epithelial cells. Biochem Biophys Res Commun. 1997 Jul 18;236(2):522-6. PMID: 9240473; UI: 97382469. These are just a few in which NF-kB comes up in the title with asthma, a search for those terms comes up with more titles which don't happen to have those terms in the title, but do apparently have them in the abstract. I like to buy a company--and then research it! --MM

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next